F isher (page 20) reviews the MATCH trial whereby clopidogrel and aspirin was compared with clopidogrel alone for secondary prevention in patients who have had a transient ischemic attack or stroke in a high-risk population with a high prevalence of other vascular risk factors. A nonsignificant trend for a reduction of the combined end point of ischemic stroke, myocardial infarction, vascular death, and rehospitalization was observed in the combination therapy group. The frequency of serious, life-threatening bleeding adverse effects was almost doubled in the combination arm. Neurologists need to be aware of these results and avoid the use of clopidogrel with aspirin in patients who have had a transient ischemic attack or stroke until evidence is provided that the combination is safe in this population. value of soluble vascular cell adhesion molecule 1 (sVCAM-1) and N-terminal pro-Btype natriuretic peptide (NT-proBNP) in patients who had a previous stroke or transient ischemic attack for future ischemic stroke. In a well-designed and detailed study, they conclude that sVCAM-1 and NT-proBNP were independent predictors of recurrent ischemic stroke. can potentially preserve cognitive function seen in the childhood cerebral phenotype of X-linked adrenoleukodystrophy. X-linked adrenoleukodystrophy should be considered as a candidate disorder for neonatal screening.
Molecular Pathogenesis of Multiple Sclerosis

Cognitive Evaluation in Asymptomatic Boys With X-linked Adrenoleukodystrophy
Sensorimotor Function and Axonal Integrity in Adrenomyeloneuropathy
Z ackowski et al (page 74) provide data to understand how sensorimotor impairments create mobility deficits and how these impairments are related to specific metrics of axonal integrity. Impairment measures capture specific abnormalities in walking and balance that can be used to direct rehabilitation therapy.
Patterns of Brain Atrophy That Differentiate Corticobasal Degeneration Syndrome From Progressive Supranuclear Palsy
B oxer and colleagues (page 81) studied the structural neuroanatomical differences between corticobasal degeneration syndrome and progressive supranuclear palsy using voxel-based morphometry on magnetic resonance images in each subject group. They found highly specific patterns of brain atrophy in corticobasal degeneration syndrome and progressive supranuclear palsy that can be used to differentiate the 2 diseases.
Neuropathology of Dementia in African American and White Individuals
W ilkins et al (page 87) report no substantive differences in the neuropathology of Alzheimer disease among African American and white participants.
